MAFA
BSX icon

MJT & Associates Financial Advisory’s Boston Scientific BSX Stock Holding History

MJT & Associates Financial Advisory’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Hold
63
– – ﹤0.01% 360
2026
Q1 		$3.95K Hold
63
– – ﹤0.01% 300
2025
Q4 		$6.01K Hold
63
– – ﹤0.01% 256
2025
Q3 		$6.15K Hold
63
– – 0.01% 262
2025
Q2 		$6.77K Hold
63
– – 0.01% 268
2025
Q1 		$6.36K Buy
+63
New +$6.34K 0.01% 273

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MJT & Associates Financial Advisory's BSX Position: Q2 2026 in Review

MJT & Associates Financial Advisory held its Boston Scientific (BSX) position steady in Q2 2026 at 63 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

MJT & Associates Financial Advisory first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.77K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MJT & Associates Financial Advisory held 63 shares of Boston Scientific worth $2.69K as of Q2 2026.
  • MJT & Associates Financial Advisory left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #360 holding.
  • MJT & Associates Financial Advisory first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • MJT & Associates Financial Advisory's Boston Scientific position peaked at $6.77K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.